These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32795372)

  • 1. Individualized approach to primary prevention of substance use disorder: age-related risks.
    Afuseh E; Pike CA; Oruche UM
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):58. PubMed ID: 32795372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HealthCare educational differences in pain management, adverse childhood experiences and their relationship to substance use disorder education.
    Ojeda MS; Chen AMH; Miracle T; Delaney E; Freiermuth CE; Sprague JE
    Subst Abuse Treat Prev Policy; 2022 Feb; 17(1):10. PubMed ID: 35130945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for secondary substance use disorders in people with childhood and adolescent-onset bipolar disorder: opportunities for prevention.
    Kenneson A; Funderburk JS; Maisto SA
    Compr Psychiatry; 2013 Jul; 54(5):439-46. PubMed ID: 23332720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention.
    Goldstein BI; Bukstein OG
    J Clin Psychiatry; 2010 Mar; 71(3):348-58. PubMed ID: 19961811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Substance use disorders as a cause and consequence of childhood abuse. Basic research, therapy and prevention in the BMBF-funded CANSAS-Network].
    Schäfer I; Barnow S; Pawils S;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Jan; 59(1):35-43. PubMed ID: 26497814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent substance use disorders and comorbidity.
    Simkin DR
    Pediatr Clin North Am; 2002 Apr; 49(2):463-77. PubMed ID: 11993293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targets for intervention to prevent substance use in young people exposed to childhood adversity: A systematic review.
    Grummitt L; Kelly E; Barrett E; Keyes K; Newton N
    PLoS One; 2021; 16(6):e0252815. PubMed ID: 34097711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared and specific associations of substance use disorders on adverse outcomes: A national prospective study.
    Franco S; Olfson M; Wall MM; Wang S; Hoertel N; Blanco C
    Drug Alcohol Depend; 2019 Aug; 201():212-219. PubMed ID: 31252355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use disorders increase the odds of subsequent mood disorders.
    Kenneson A; Funderburk JS; Maisto SA
    Drug Alcohol Depend; 2013 Dec; 133(2):338-43. PubMed ID: 23906994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance Misuse Profiles of Women in Families Receiving Temporary Assistance for Needy Families (TANF) Benefits: Findings from a National Sample.
    Oh S; Salas-Wright CP; Vaughn MG; Zapcic I
    J Stud Alcohol Drugs; 2020 Nov; 81(6):798-807. PubMed ID: 33308410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities.
    Van de Glind G; Brynte C; Skutle A; Kaye S; Konstenius M; Levin F; Mathys F; Demetrovics Z; Moggi F; Ramos-Quiroga JA; Schellekens A; Crunelle C; Dom G; van den Brink W; Franck J
    Eur Addict Res; 2020; 26(4-5):173-178. PubMed ID: 32599579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of substance use and its outcomes by machine learning I. Childhood evaluation of liability to substance use disorder.
    Jing Y; Hu Z; Fan P; Xue Y; Wang L; Tarter RE; Kirisci L; Wang J; Vanyukov M; Xie XQ
    Drug Alcohol Depend; 2020 Jan; 206():107605. PubMed ID: 31839402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood Abuse, Religious Involvement, and Lifetime Substance Use Disorders among Latinas Nationwide.
    Ai AL; Lee J
    Subst Use Misuse; 2018 Nov; 53(13):2099-2111. PubMed ID: 29624121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Project Extension for Community Healthcare Outcomes to Enhance Substance Use Disorder Care in Primary Care: Mixed Methods Study.
    Koester M; Motz R; Porto A; Reyes Nieves N; Ashley K
    JMIR Med Educ; 2024 Apr; 10():e48135. PubMed ID: 38557477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Eur Addict Res; 2020; 26(4-5):223-232. PubMed ID: 32634814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pattern of substance use disorder in the United Arab Emirates in 2015: results of a National Rehabilitation Centre cohort study.
    Alblooshi H; Hulse GK; El Kashef A; Al Hashmi H; Shawky M; Al Ghaferi H; Al Safar H; Tay GK
    Subst Abuse Treat Prev Policy; 2016 May; 11(1):19. PubMed ID: 27177422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States.
    McCabe SE; Wilens TE; Boyd CJ; Chua KP; Voepel-Lewis T; Schepis TS
    Addict Behav; 2019 Mar; 90():285-293. PubMed ID: 30472537
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.